GeneTherapy.ISTH.org - Gene Therapy Latest News

BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval

BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval

13 May 2020

Phase 3 Trial of AMT-061 Gene Therapy for Hemophilia B Exceeds Target Dosing

Phase 3 Trial of AMT-061 Gene Therapy for Hemophilia B Exceeds Target Dosing

27 March 2020

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia

17 April 2020

Hemophilia Gene Therapy Knowledge and Perceptions: Results of an International Survey

Hemophilia Gene Therapy Knowledge and Perceptions: Results of an International Survey

19 March 2020

Gene & Anti-TFPI Therapies in Hemophilia: Competitive Grant Program
18 March 2020
New Gene Therapy Shows Promise in Hemophilia A Mouse Model, Study Shows
17 March 2020
High Dose of Gene Therapy for Hemophilia B Normalizing FIX Levels, Early Trial Data Show
18 February 2020
Human Gene Therapy for Hemophilia
04 February 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL